SAN MATEO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. announced that on Thursday, September 4, 2008, it will report its financial results for its fourth quarter and fiscal year ended June 30, 2008. The Company will issue the earnings press release after the NASDAQ Global Market closes and will hold a conference call with investors at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).
BioForm Medical Chief Executive Officer Steve Basta and Chief Financial Officer Derek Bertocci will discuss the Company's results for the fourth quarter and fiscal year ended June 30, 2008. The conference call will be webcast live on the Investor Relations section of BioForm Medical's website at http://www.bioform.com. The online archive of the broadcast will be available approximately 90 minutes after the live call and will continue to be available for four weeks.
The conference call may be accessed by dialing 888-287-5530 for callers in the U.S. and 719-785-1768 for international callers. Please notify the operator that you would like to join "BioForm Medical's Fourth Quarter & Fiscal 2008 Earnings Call" and provide the participant code "2257477", if prompted.
About BioForm Medical, Inc.:
BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California, developing products that enhance aesthetic procedures performed in dermatology and plastic surgery practices. BioForm Medical's lead product is Radiesse(R) dermal filler, a long-lasting filler for use in facial aesthetics. BioForm Medical is developing several future aesthetics products, including a radiofrequency treatment to reduce nerve function in the forehead, a sclerotherapy treatment for spider veins, and a surgical adhesive for brow lifts. For more information about BioForm, please visit http://www.bioform.com.
CONTACT: Adam Gridley, Vice President, Corporate Development of BioForm
Medical, Inc., +1-650-286-4025
Web site: http://www.bioformmedical.com/